MICHELETTO, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 1.110
NA - Nord America 1.071
AS - Asia 560
SA - Sud America 18
AF - Africa 6
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.769
Nazione #
US - Stati Uniti d'America 1.057
GB - Regno Unito 337
CN - Cina 292
IT - Italia 229
SG - Singapore 181
SE - Svezia 99
RU - Federazione Russa 90
FR - Francia 86
IE - Irlanda 75
DE - Germania 67
FI - Finlandia 49
JP - Giappone 25
PL - Polonia 23
HK - Hong Kong 15
UA - Ucraina 15
BR - Brasile 14
BE - Belgio 12
ID - Indonesia 12
CA - Canada 11
IN - India 8
MY - Malesia 7
TG - Togo 6
AT - Austria 5
CZ - Repubblica Ceca 4
KR - Corea 4
VN - Vietnam 4
CH - Svizzera 3
ES - Italia 3
LT - Lituania 3
NL - Olanda 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
HU - Ungheria 2
MX - Messico 2
PE - Perù 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.769
Città #
Southend 280
Chandler 226
Singapore 139
Jacksonville 125
Ashburn 82
Dublin 75
Redmond 69
Ann Arbor 59
Beijing 51
Verona 44
Houston 43
Woodbridge 41
New York 39
Lawrence 32
Princeton 32
Boardman 27
Jinan 25
Wilmington 25
Helsinki 22
Milan 22
Sindelfingen 21
Tokyo 19
Changsha 18
Rome 18
Shenyang 16
Nanjing 15
Bologna 13
Ningbo 13
Hong Kong 12
Jakarta 12
Taizhou 12
Zhengzhou 11
Brussels 10
Seattle 10
Hebei 9
Tianjin 9
Dallas 8
Falls Church 8
Haikou 8
Lanzhou 8
Kuala Lumpur 7
Taiyuan 7
Toronto 7
City of Westminster 6
Fuzhou 6
Jiaxing 6
Kent 6
Lomé 6
Auburn Hills 5
Chicago 5
Frankfurt am Main 5
Hangzhou 5
Lancaster 5
London 5
Los Angeles 5
Munich 5
Naples 5
Norwalk 5
Redwood City 5
Ancona 4
Boydton 4
Brescia 4
Brno 4
Delhi 4
Dongguan 4
Lozzo Atestino 4
Palermo 4
Seoul 4
Catania 3
Düsseldorf 3
Guangzhou 3
Menlo Park 3
Moscow 3
Nanchang 3
Negrar 3
Ottawa 3
Riyadh 3
Santa Clara 3
Shanghai 3
Turin 3
Vienna 3
Abbiategrasso 2
Acquedolci 2
Altopascio 2
Baku 2
Bari 2
Barnet 2
Bonsecours 2
Chennai 2
Clearwater 2
Cortona 2
Debrecen 2
Dong Ket 2
Dubai 2
Genoa 2
Ghent 2
Grezzana 2
Hendaye 2
Huskvarna 2
Isola del Gran Sasso 2
Totale 1.927
Nome #
Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity. 253
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 205
A two-stage logistic Model Based on the Measurament of Pro-Infectious Cytokines in Bronchial Secretions for Assessing Bacterial, Viral and Non-Infectious Origin of COPD Exacerbation - Original Research 110
Assessment of COVID-19 progression on day 5 from symptoms onset 103
A MCh test pre-post esophageal acidification in detecting GER-related asthma. 102
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. 94
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. 93
Effect of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma 85
Reference urinary LTE4 levels in normal individuals: a pilot study. 85
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 84
Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. 79
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? 79
PATTERN OF AIRWAY INFLAMMATION AND REMODELLING IN MILD PERSISTENT ATOPIC ASTHMA AND IN MILD PERSISTENT ASTHMA RELATED TO GASTROESOPHAGEAL REFLUX 78
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 77
Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. 74
PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring. 74
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 73
Omalizumab management beyond clinical trials: the added value of a network model 69
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 68
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 67
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 67
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 65
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 64
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 62
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 61
Nasal and Bronchial Tolerability of Rofecoxib in Patients with Aspirin induced Asthma 58
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 55
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 55
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 54
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 50
Multidisciplinary management in type 2 inflammatory disease 48
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 42
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 37
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 34
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol 32
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 22
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 22
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy 17
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 17
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence 12
Totale 2.826
Categoria #
all - tutte 10.667
article - articoli 10.667
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 0 16 5 12 3 17 37 19
2020/2021327 82 41 4 34 30 31 19 12 20 19 29 6
2021/2022366 52 113 12 22 8 9 5 22 13 8 25 77
2022/2023628 39 71 56 110 64 120 7 33 73 6 30 19
2023/2024497 27 38 47 47 45 78 26 36 12 28 77 36
2024/2025436 78 59 48 158 50 43 0 0 0 0 0 0
Totale 2.826